ArticleCancer medicine2023

Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators.

Kim Westerdijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.